COMPARATIVE EVALUATION OF TREATMENT PERSISTENCE AND DOSE INTENSIFICATION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB VERSUS VEDOLIZUMAB
Michael Chiorean 1
Jeanne Jiang 2
Ninfa Candela 2
Grace Chen 2
Hela Romdhani 3
Dominick Latremouille-Viau 3
Sherry Shi 3
Rebecca Bungay 3
Tao Fan 3
1 Virginia Mason Medical Center, Seattle, United States
2 Takeda Pharmaceuticals, Lexington, United States
3 Analysis Group, Inc, Montreal, Canada
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]